1. The Role of IL-33-Dependent Inflammation in the Tumor Microenvironment
   Marie-Hélène Wasmer et al, 2017, Frontiers in Immunology CrossRef
2. Genetic variants in IL-33/ST2 pathway with the susceptibility to hepatocellular carcinoma in a Chinese population
   Zhong-Heng Wei et al, 2019, Cytokine CrossRef
3. IL-33 Released in the Liver Inhibits Tumor Growth via Promotion of CD4+ and CD8+ T Cell Responses in Hepatocellular Carcinoma
   Ziqi Jin et al, 2018, The Journal of Immunology CrossRef
4. Interleukin-1 family cytokines in liver cell death: a new therapeutic target for liver diseases
   Wanvisa Udomsinprasert, 2023, Expert Opinion on Therapeutic Targets CrossRef
5. Interleukin-1 Family Cytokines: Keystones in Liver Inflammatory Diseases
   Louise Barbier et al, 2019, Frontiers in Immunology CrossRef
6. SUMOylated IL-33 in the nucleus stabilizes the transcription factor IRF1 in hepatocellular carcinoma cells to promote immune escape
   Zengbin Wang et al, 2023, Science Signaling CrossRef
7. Establishment of an Immunocompetent Metastasis Rat Model with Hepatocyte Cancer Stem Cells
   Semon Wu et al, 2020, Cancers CrossRef
8. IL-33-ST2 Axis in Liver Disease: Progression and Challenge
   Zijian Sun et al, 2017, Mediators of Inflammation CrossRef
9. The DNA methylation profile of liver tumors in C3H mice and identification of differentially methylated regions involved in the regulation of tumorigenic genes
   Junya Matsushita et al, 2018, BMC Cancer CrossRef
10. The association of serum IL-33/ST2 expression with hepatocellular carcinoma
    Xiaolan Pan et al, 2023, BMC Cancer CrossRef